This website uses cookies so that we can provide the best service possible. For more information, please visit our privacy policy.

sign in


Sep 17, 2020

successful agile antiviral drug discovery in a start-up environment

guest speaker:
Dr. Adrian Schomburg, CEO Eisbach Bio GmbH, Munich, Germany

An agile, lean and partially in-silico drug discovery pipeline is key to the success of start-up companies that pursue their small molecule drug discovery goals on a limited budget.
We all have billion dollar figures in mind for an approved drug, but the early stage drug discovery, up to an investigational new drug application, consumes only a small fraction of this cost.

In this webinar, Dr. Adrian Schomburg from Eisbach Bio explains how an agile drug discovery platform is a key success factor, especially in a pandemic situation: Tools that Eisbach has lined up for cancer discovery projects were quickly adapted to screen for novel inhibitors of a key SARS-CoV-2 enzyme, from idea to antiviral activity in only two months. These include MD-based and AI-augmented compound docking, visual inspection and refinement, biochemical, ADMET and cell based anti-viral screening as well as PK.

We cordially invite you to join Adrian with us in this exciting webinar.

Jul 07, 2020

unlocking chemical matter on scale

guest speaker:
Dr. Serghei Glinca, CEO Crystals First GmbH, Marburg, Germany

Jun 18, 2020

web-based services for structure-based life science research

guest speaker:
Prof. Dr. Matthias Rarey, Center for Bioinformatics, Hamburg, Germany

May 19, 2020

chemical space exploration — finding needles in mighty haystacks

Dr. Franca Klingler, Head of Services, BioSolveIT GmbH, Sankt Augustin, Germany

load more


© 2020 BioSolveIT GmbH,   all rights reserved